ArticleJournal of translational medicine2016

Evaluation of the biomarker candidate MFAP4 for non-invasive assessment of hepatic fibrosis in hepatitis C patients.

Thilo Bracht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.